Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 3 | BES2002 | Next issue

21st Joint Meeting of the British Endocrine Societies

Poster Presentations


ea0003p177 | Neuroendocrinology | BES2002

Growth hormone deficient patients over 60 years require a low dose of GH and short titration phase to achieve normal serum IGF-I levels

Mah P , Newell-Price J , Doane A , Ibbotson V , Ho K , Ross R

AIM: 1) To determine GH dose requirement in GH deficient patients aged over 60 years. METHODS: The study was approved by the local Ethics Committee. Patients were started on Genotropin 0.4 units (0.13 mg)/day after baseline assessment. Serum IGF-I was repeated at 2-weekly intervals. Maintenance GH dose was achieved when serum IGF-1 was between the median and upper end of the age-related range. RESULTS: 16 patients (10 men & 6 women) were recruited. Their median (range) age...

ea0003p178 | Neuroendocrinology | BES2002

A relationship between interleukin-1 and interleukin-6 secretion by human pituitary adenomas in culture

Kerry K , Borg S , Jones T

There is increasing evidence that cytokines may play an important role in the pathogenesis of human pituitary adenomas. We have measured the production of interleukin-1 alpha from 30 cultured human pituitary adenomas and looked at the relationship of its secretion to interleukin-6 and soluble gp130. Tumours were also analysed for interleukin-2 secretion. We also used the HP75 cell line to look at the effects of varying levels of interleukin-1 on interleukin-6 secretion.<p...

ea0003p179 | Neuroendocrinology | BES2002

Time dependency of somatotroph dysfunction following radiation damage of the hypothalamic-pituitary axis

Darzy K , Ghigo E , Shalet S

Radiation-induced growth hormone neurosecretory dysfunction (GHNSD) is, primarily, the result of radiation-induced hypothalamic damage. Consequently, reduced hypothalamic growth hormone releasing hormone (GHRH) secretion results in secondary somatotroph atrophy and attenuated peak GH responses to a bolus of exogenous GHRH. For the first time we have studied the presence of GHNSD and/or somatotroph atrophy in cranially irradiated adult survivors of childhood cancer. We have uti...

ea0003p180 | Neuroendocrinology | BES2002

Ghrelin is acutely regulated by insulin but not glucose

Flanagan D , Evans M , Monsod T , Rife F , Heptulla R , Tamborlane W , Sherwin R

Ghrelin is a novel peptide that acts on the growth hormone segratagogue receptor in the pituitary and hypothalamus. It functions as a third physiological regulator of GH secretion along with GHRH and somatostatin. In addition to the action of ghrelin on the GH axis it appears to have a role in the determination of energy homeostasis. Whilst feeding suppresses ghrelin production and fasting stimulates ghrelin release the underlying mechanisms controlling this process remain unc...

ea0003p181 | Neuroendocrinology | BES2002

Gender differences in the relationship between leptin and the autonomic nervous system

Flanagan D , Vaile J , Petley G , Moore V , Godsland I , Cockington R , Robinson J , Phillips D

Leptin is a crucial hormone in the regulation of body weight. It is produced by adipose tissue and acts centrally decreasing appetite and increasing energy expenditure. Leptin has been shown to stimulate sympathetic nervous system activity in vitro although the physiological relevance of this remains unclear. Increased sympathetic nervous system (SNS) activity has been implicated in the pathogenesis of insulin resistance and a greatly increased cardiovascular risk. We have the...

ea0003p182 | Neuroendocrinology | BES2002

Magnetic resonance perfusion enables assessment of blood supply to pituitary gland

Turner H , Jezzard P , Levy J , Matthews P , Wass J , Byrne J

Background: Over 90% of the blood supply to the adenohypophysis arises from hypothalamic portal vessels, in contrast to the systemic blood supply to the posterior lobe. A pre-existing, or tumour stimulated direct (non-portal) blood supply has been suggested as a possible pathogenic mechanism for prolactinoma development.Methods: 6 patients (3 microprolactinomas (mic), and 3 macroprolactinomas (mac)), and one control subject were imaged using a 3T magnet...

ea0003p183 | Neuroendocrinology | BES2002

Long term treatment of adult growth hormone deficiency does not normalise quality of life compared to control subjects: A need for a different strategy?

Malik I , Groves T , Wallymahmed M , Wilding J , MacFarlane I

Background: numerous studies using a variety of quality of life (QOL) measures have shown multiple impairments in adults with growth hormone deficiency (GHD) compared to control subjects. There have been few studies however of QOL in a treated GHD population compared with healthy controls.Method: 120 adults with treated GHD ( >1 year) were given the following QOL questionnaires at annual review: SF36, Nottingham Health Profile, Disease Impact, Life F...

ea0003p184 | Neuroendocrinology | BES2002

Expression and purification of histidine-tagged anosmin-1 by drosophila S2 cells and Ni-NTA agarose chromatography

Hu Y , Bouloux P , MacColl G

Introduction: Anosmin-1, which is implicated in the pathogenesis of X-linked Kallmann`s syndrome, consists of a cysteine rich region, followed by a WAP domain and 4 fibronectin type III (FN3) domains. The N-terminal region of anosmin-1, WAP and 1st FN3 domain, is highly conserved in a wide variety of species which suggests that the activity of the protein resides in these conserved segments. Difficulties in the expression of the full-length anosmin-1 by Chinese hamster ovary c...

ea0003p185 | Neuroendocrinology | BES2002

Cardiac sympathovagal balance correlates positively with age in growth hormone deficient (GHD) patients

Leong K , Malik I , Wallymahmed M , MacFarlane I , Wilding J

Background: We previously demonstrated that elderly patients with GHD have increased and young GHD patients have reduced cardiac sympathovagal balance. Therefore we decided to investigate whether the relationship between age and cardiac sympathovagal balance is altered in GHD compared to healthy controls.Method: HRV, which indirectly measures cardiac sympathovagal balance, was measured in 22 untreated GHD patients (13 F; mean age 47.4 yrs; range 19-73 y...

ea0003p186 | Neuroendocrinology | BES2002

The pattern of green fluorescent protein (GFP) expression following intrahypothalamic injection of adeno-associated virus-GFP

Ward H , Gardiner J , Kong W , Murphy K , Bloom S

Adeno-associated virus (AAV) has been used to express GFP in a variety of tissues. AAV has a tropism for neurones and we have been using AAV-GFP to determine the anatomical localisation of gene transfer after injection into the hypothalami of Wistar rats. The long term aim is to use this viral vector as a tool for investigating the hypothalamic control of appetite, energy expenditure and pituitary function.Male Wistar rats were anaesthetised and injecte...

ea0003p187 | Neuroendocrinology | BES2002

The effect of serotonin on the GH, T3, T4, milk production and composition

Khazali H

The goal of this study was to determine whether injections of serotonin increase the plasma concentration of thyroxine (T4) , triiodothyronine (T3), growth hormone (GH), milk amount and constituents in the cows. sixty cows were randomly divide into 4 groups. Each group received daily injections of either saline or 1, 2, 4 milligrams serotonin per Kg for 15 days. Blood samples were collected daily on day 3 before injections untill 3 days after the last injection . Samples were ...

ea0003p188 | Neuroendocrinology | BES2002

Diet-induced obesity in the Sprague-Dawley (SD) rat

Archer Z , Rayner D , Mercer J

The consumption of a high energy (HE) diet causes a range of weight gain responses in the human population with some individuals resistant to diet induced obesity (DIO). The SD rat provides a model for DIO and this study examines the effects of HE diet on bodyweight, food intake and hypothalamic neuropeptide gene expression. 28 male out-bred SD rats (280.7±2.19g) were fed chow ad-libitum (AL) for 4 days then divided into 2 weight-matched groups: 20 rats were fed HE diet...

ea0003p189 | Neuroendocrinology | BES2002

The correlation between serum insulin-like growth factor 1 levels and creatinine clearance in adults with growth hormone deficiency

Al-Mrayat M , Donaldson O , Anyaoka V , Johnston D

Insulin like growth factor-1 (IGF-1) has been shown to co-vary with renal function in a number of physiological and pathological conditions. However, this relationship and possible co-variants have not been specifically explored in untreated growth hormone deficient adults (GHDA). To examine this issue, we studied 24 GHDA subjects (14M, 10F) in the fasted state twice after obtaining consent and ethical approval. The Cockcroft and Gault equation was used to calculate creatinine...

ea0003p190 | Neuroendocrinology | BES2002

Functional neurosecretory GnRH deficiency in a man with adult onset hypogonadotrophic hypogonadism: an unrecognised entity?

Silveira L , Thomas M , Bouloux P

Hypothalamic GnRH neuronal dysfunction is a frequent cause of hypogonadotrophic hypogonadism (HH) in women with secondary amenohrroea. However, the entity is poorly characterized in men, possibly due to lack of a sensitive equivalent clinical marker of the condition.A 40-year-old man presented with a 7-year history of progressive lack of energy, loss of libido, decreased sexual function, and loss of morning erections. Puberty had occurred normally and h...

ea0003p191 | Neuroendocrinology | BES2002

Precipitating factors and surgical outcome in pituitary apoplexy

Levy M , Pollock J , Baldeweg S , Conway G , Powell M

Pituitary apoplexy is a rare condition caused by haemorrhage or infarction into a pituitary tumour. The majority of patients do not have any identifiable triggering event, although situations altering the blood flow to the pituitary gland and pre-existing systemic hypertension have been identified as potential causal factors.We retrospectively reviewed the presentation and outcome of 15 patients with pituitary apoplexy (8 men, 7 women; age 16-87, mean 5...

ea0003p192 | Neuroendocrinology | BES2002

Single centre audit of surgical outcome in Cushing's disease

Baldeweg S , Pollock J , Kane P , Levy M , Akinwunmi J , Conway G , Powell M

We examined the results of treatment of adult Cushing's disease by transphenoidal surgery by a single neurosurgeon (MP). Patients with Nelson's syndrome and those who previously had received treatment for Cushing's by a different surgeon were excluded. We reviewed the pituitary database and patient records for all patients operated between 1988 and 2000 with clear pre-operative evidence of Cushing's disease. 117 patients had clear evidence of a pituitary source of excess ACTH....

ea0003p193 | Neuroendocrinology | BES2002

Leptin and leptin receptors are developmentally regulated in rat pituitary

Morash B , Imran S , Ur E , Wilkinson M

We reported that leptin mRNA is developmentally regulated and hypothesized that local leptin expression is important for the maturation of the hypothalamic-pituitary system. Pituitary leptin mRNA levels were down-regulated in early postnatal male and female rats. We now show that pituitary leptin protein content and expression of the long (OBRb) and short (OBRa) leptin receptor isoforms in the pituitary and hypothalamus also undergo age-related changes. Tissue wa...

ea0003p194 | Neuroendocrinology | BES2002

Influence of age on the vulnerability of the hypothalamic-pituitary axis to radiation damage

Gleeson H , Baylis C , Shalet S

Survival figures following the treatment of brain tumours continue to improve. Patients receiving cranial radiotherapy (XRT) frequently suffer a progressive loss of anterior pituitary function secondary to radiation damage to the hypothalamic pituitary axis (HPA), therefore long-term follow up is required. The time frame of radiation damage to the HPA is not known. There is also a suggestion from animal data that the HPA is more sensitive to damage by radiation when treated at...

ea0003p195 | Neuroendocrinology | BES2002

Weight gain and obesity in patients with hypothalamic damage

Daousi C , MacFarlane I , Pinkney J

Background: Weight gain is underrecognised in patients with hypothalamic damage and the prevalence and mechanisms are poorly defined. The aim of this study was to define the diagnoses and endocrine characteristics associated with weight gain.Subjects and methods: A retrospective study of 48 patients (25 female) mean (SD) age 45.3yrs (9.8).They included 22 patients with primary hypothalamic lesions (craniopharyngiomas, Rathke's cysts and other tumours)[g...

ea0003p196 | Neuroendocrinology | BES2002

Urinary catecholamines and catecholamine-metabolites in the immediate post-operative period following coronary revascularization surgery

Syed A , Wheatley H , Badminton M , McDowell I

OBJECTIVE Induction of anaesthesia and surgical stress, factors known to trigger catecholamine release from phaeochromocytomas, are believed to result in elevated levels in the postoperative period even in the absence of such tumours, and biochemical screening is usually deferred for two or more weeks following surgery. The aim of this study was to determine patterns of peri-operative urinary catecholamine excretion in otherwise healthy subjects undergoing a single type of maj...

ea0003p197 | Neuroendocrinology | BES2002

The effect of bombesin on the Gh, T3, T4 and milk production and compositions

Khazali H

The goal of this study was to determine whether injections of bombesin increase the plasma concentration of thyroxine (T4) , triiodothyronine (T3), growth hormone (GH), milk amount and constituents in the cows. sixty cows were randomly divide into 4 groups. Each group received daily injections of either saline or 1, 2, 4 milligrams bombesinper kilogram for 15 days. Blood samples were collected daily on day 3 before injections untill 3 days after the last injection . Samples we...

ea0003p198 | Neuroendocrinology | BES2002

Functional complement C3a receptors in the rat pituitary gland

Lewis B , Francis K , Gasque P , Scanlon M , Ham J

The hypothalamic pituitary adrenal (HPA) axis is the major regulator of stress and inflammation via the secretion of anti-inflammatory corticosteroids. This suggests an important bidirectional flow of information between the endocrine and immune systems. A critical component of the inflammatory response is the complement cascade in which anaphylatoxins C3a, C4a and C5a are released.In this report we used colocalisation immunohistochemistry to show detai...

ea0003p199 | Neuroendocrinology | BES2002

Serum IGF-I levels and correlation with functional activity in the elderly

Jenkins P , Barber M , Camacho-Hubner C , Braid V , Gilmore D , Stott D

Introduction: Ageing is associated with a decrease in activity of the growth hormone / IGF-1 axis. However, there is little normative data for serum IGF-I levels in the very elderly and the relationship of IGF-1 levels to muscle function and physical performance in geriatric inpatients has not been fully explored. We studied elderly patients rehabilitating after proximal femoral fracture (PFF), hypothesising that patients with lower circulating IGF-1 levels would have poorer p...

ea0003p200 | Neuroendocrinology | BES2002

Disease activity in acromegaly may be assessed four weeks after discontinuation of pegvisomant

Drake W , Loureiro R , Parkinson C , Roberts M , Akker S , Monson J , Besser G , Trainer P

Patients with acromegaly treated with medical therapy intermittently discontinue therapy to allow assessment of underlying disease activity. This is particularly so in patients treated with pituitary irradiation. Typical 'washout' times include 5 weeks for bromocriptine and 2 weeks for short-acting sc octreotide; longer periods are required for cabergoline and slow-release somatostatin analogues. Pegvisomant is a novel medical therapy for acromegaly that functions as a GH rece...

ea0003p201 | Neuroendocrinology | BES2002

Outcome of treatment for Cushing's disease in Birmingham; the experience of a single surgeon

Dale J , McGregor E , Johnson A , Gittoes N

Transsphenoidal surgery (TSS) is the most common first-line treatment for Cushing's disease (CD). We have examined the outcome of this intervention to identify pre-operative clinical factors that predict good surgical outcome and to determine the risk of adverse events.We performed a case-notes review of 30 consecutive patients, 20 (67%) female, treated by a single surgeon over a 14-year period. The mean (SE) age was 34.2 (2.1) years and median (range) ...

ea0003p202 | Neuroendocrinology | BES2002

Beta-adrenergic input exerts both acute and chronic effects on steroid production in H295R human adrenocortical cells

Kosti O , King P , Hinson J

It is well established that catecholamines have potent actions on adrenocortical function and steroidogenesis in different species. The effect of these substances on steroid production of the human adrenal cell line H295R is the subject of this study. H295R is the first adrenocortical cell line capable of secreting the normal range of adrenal steroid products (i.e. mineralocorticoids, glucocorticoids and adrenal androgens) and since free of chromaffin cells, it appears to be a...

ea0003p203 | Neuroendocrinology | BES2002

Neuropeptides and adrenocortical proliferation in vitro

Whitworth E , Hinson J , Vinson G

Vasoactive intestinal peptide (VIP) and Neuropeptide Y (NPY) are well established paracrine regulators of adrenal function. These neuropeptides have recently been immunolocalised to the capsule and zona glomerulosa region of the adrenal cortex, where they play a role in regulating steroidogenesis and adrenal blood flow. Neural mediation of compensatory adrenal growth following unilateral adrenalectomy and stimulation of proliferation and vascular hypertrophy in vascular smooth...

ea0003p204 | Neuroendocrinology | BES2002

Growth hormone (GH) deficiency in adults treated for acute lymphoblastic leukaemia (ALL) in childhood

Ayuk J , McGregor E , Mann J , Stewart P , Toogood A

The number of patients treated for malignant disease in childhood surviving into adulthood is increasing, but success is tempered by long-term side-effects of chemotherapy and radiotherapy; 40% develop one or more endocrinopathy. ALL is a common childhood malignancy treated with chemotherapy and cranial irradiation. The latter causes anterior pituitary hormone deficiencies, most frequently GH deficiency.We have determined GH status in 13 patients treate...

ea0003p205 | Neuroendocrinology | BES2002

Outcomes in the management of pituitary apoplexy; a conservative approach may be prudent

McGregor E , Ayuk J , Gittoes N

Due to the infrequency of pituitary apoplexy, there are no robust evidence-based guidelines for optimum care of these patients. The key controversy surrounds the role of acute neurosurgical intervention. Over recent years we have adopted a relatively conservative approach and the aim of this study was to determine whether this 'non-intervention' affected long-term outcome in a recent cohort of patients. 19 patients (8 female) presented between 1994-2001. Mean age at diagnosis ...

ea0003p206 | Neuroendocrinology | BES2002

Prolactin releasing peptide does not have a significant role in the control of growth hormone secretion either in vitro or in vivo in freely moving male rats

Seal L , Small C , Wren A , Dhillo W , Ghatei M , Bloom S

Prolactin releasing peptide (PrRP) is reported to decrease plasma growth hormone (GH) levels in the rat but increase GH release from human pituitary cells. A barbiturate anaesthetised model was used in the rat studies (where basal plasma growth hormone is elevated) and in humans the GH stimulatory effects were of a small magnitude and seen only in foetal or tumourous pituitary cells. Our studies have examined the role of PrRP in freely moving male rats without the influence of...

ea0003p207 | Neuroendocrinology | BES2002

Measures of cardiovascular parameters in patients with acromegaly switched from SC octreotide to Sandostatin-LAR

Smith W , Oldroyd B , Belchetz P , Sivananthan M , Orme S

Studies have demonstrated an increased mortality in patients with acromegaly. The major cause of premature death was cardiovascular disease. Cardiovascular mortality was increased in patients with high levels of growth hormone (GH). Somatostatin analogues, such as octreotide, are effective in relieving the symptoms of acromegaly and supressing GH hypersecretion. Long acting preparations, such as Sandostatin-LAR, offer theoretical advantages over SC preparations, such as improv...